Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billion

Retrieved on: 2022-12-12 18:47:05

Tags for this article:

Click the tags to see associated articles and topics

Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billion. View article details on hiswai:

Excerpt

Biotechnology. Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billion. Published: Dec. 12, 2022 at 6:29 a.m. ET.

Article found on: www.marketwatch.com